Avai Bio (AVAI) Invested Capital (2018 - 2025)

Avai Bio has disclosed Invested Capital across 8 years of filings, most recently posting -$2.2 million for Q4 2025.

• Invested Capital for Q4 2025 came in at -$2.2 million, down 205.1% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.2 million (down 205.1% YoY), and the FY2025 annual result was -$1.6 million, down 6.63% from the prior year.
• Invested Capital came in at -$2.2 million for Q4 2025 at Avai Bio, down from -$2.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.1 million in Q4 2024 to a low of -$2.2 million in Q4 2025.
• The 5-year median for Invested Capital is -$484610.0 (2022), against an average of -$656014.5.
• Peak annual rise in Invested Capital reached 454.61% in 2021, while the deepest fall reached 750.43% in 2021.
• Avai Bio's Invested Capital stood at -$274858.0 in 2021, then retreated by 17.45% to -$322814.0 in 2022, then slumped by 333.96% to -$1.4 million in 2023, then jumped by 252.45% to $2.1 million in 2024, then sank by 205.1% to -$2.2 million in 2025.
• The last three Invested Capital figures came in at -$2.2 million (Q4 2025), -$2.2 million (Q3 2025), and -$1.9 million (Q2 2025), per Business Quant data.